Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
1/3 There’s some lament re:orphan grants on secondary indications. But we also see promising uses of approved drugs in very rare diseases go unstudied. Could we change incentive structure when it comes to secondary indications to better target unmet need? QT @statnews: The Orphan Drug Act has created lots drugs for rare diseases. But, Scott Gottlieb says, the times may be changing. https://t.co/BBR4bsW1JZ)
It looks like this tweet was replaced by the next tweet from @SGottliebFDA.